Could an illegal psychedelic substance ease the opioid crisis? Daniel Cameron wants to find out.
The head of the commission that manages Kentucky’s opioid-settlement money said Wednesday that the panel will “explore the possibility” of committing “no less than $42 million” to developing a treatment of opioid-use disorder with the psychedelic drug ibogaine, which is not legal in the United States. Gov. Andy Beshear questioned the idea and said it […]